Item
4.01 Change in Registrant’s Certifying Accountant
(i)
Paritz
& Company, P.A. (“Paritz”), the independent registered public accounting firm to Vycor Medical, Inc. (the “Company”),
announced effective October 9, 2018, that Paritz was acquired by a new auditing firm, Prager Metis CPA’s LLC (“Prager”),
and that all of the employees and partners of Paritz were joining Prager.
(ii)
As
a result, effective October 9, 2018, Paritz resigned as the Company’s independent registered public accounting firm. The
Company’s Board of Directors engaged Prager to serve as the Company’s independent registered public accounting firm
effective October 9, 2018.
(iii)
The reports of Paritz
on the financial statements of the Company as of and for the fiscal years ended December 31, 2017, contained no adverse opinion
or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope, or accounting principles, except
that the audit reports on the financial statements of the Company for the year ended December 31, 2017 contained a modification
expressing substantial doubt regarding the Company’s ability to continue as a going concern.
(iv)
During
the Company’s fiscal years ended December 31, 2017 and the subsequent interim period from January 1, 2018 to the date of
this report, and in connection with the audit of the Company’s financial statements for such periods, there were no disagreements
between the Company and Paritz on any matter of accounting principles or practices, financial statement disclosure, or auditing
scope or procedure, which disagreements, if not resolved to the satisfaction of Paritz, would have caused Paritz to make reference
to the subject matter of such disagreements in connection with its audit reports on the Company’s financial statements.
(v)
During
the Company’s fiscal years ended December 31, 2017, and the subsequent interim period from January 1, 2018 to the date of
this report, there were no reportable events within the meaning of Item 304(a)(1)(v) of Regulation S-K.
(vi)
During
the Company’s fiscal years ended December 31, 2017, and the subsequent interim period from January 1, 2018 to the date of
this report, the Company did not consult with Prager regarding any of the matters set forth in Items 304(a)(2)(i) and (ii) of
Regulation S-K.
(vii)
The
Company has provided Paritz with a copy of the disclosures in this report and has requested that Paritz furnish it with a letter
addressed to the Securities and Exchange Commission stating whether or not Paritz agrees with the statements in this Item 4.01.
A copy of this letter is filed as Exhibit 16.1 to this report.